Lista de obras - Cynthia Comella - Dominio Público Uruguay

123 Long-Term Outcomes with Valbenazine 40 mg/day in Adults With Tardive Dyskinesia

scientific article published on 01 April 2020

140 Effects of Long-Term Valbenazine on Tardive Dyskinesia in KINECT 4: Post Hoc Response and Shift Analyses

artículo científico publicado en 2020

77 Long-term Valbenazine Treatment in Patients with Schizophrenia/Schizoaffective Disorder or Mood Disorder and Tardive Dyskinesia

A Phase 3, 1-Year, Open-Label Trial of Valbenazine in Adults With Tardive Dyskinesia

scientific article published on 01 November 2019

A randomized, controlled trial of remacemide for motor fluctuations in Parkinson's disease

artículo científico publicado en 2001

A randomized, double-blind study of repeated incobotulinumtoxinA (Xeomin(®)) in cervical dystonia

scientific article published on 19 June 2013

A teaching videotape for the assessment of essential tremor

artículo científico publicado en 2001

A two-year randomized controlled trial of progressive resistance exercise for Parkinson's disease.

artículo científico publicado en 2013

An international survey of patients with cervical dystonia

artículo científico publicado en 2015

Assessment: Botulinum neurotoxin for the treatment of movement disorders (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology

artículo científico publicado en 2008

Association of daytime napping and Parkinsonian signs in Alzheimer's disease

artículo científico publicado en 2006

Basal ganglia hypoactivity during grip force in drug naïve Parkinson's disease

artículo científico publicado en 2010

Benefits and Risks of Pharmacological Treatments for Essential Tremor

artículo científico publicado el 1 de enero de 2003

Beyond a motor disorder: a prospective evaluation of sleep quality in cervical dystonia

artículo científico publicado en 2014

Blood oxygenation level-dependent activation in basal ganglia nuclei relates to specific symptoms in de novo Parkinson's disease

artículo científico publicado en 2010

CPNP 2020 Annual Meeting Poster Abstracts

publication published on 01 May 2020

Cervical dystonia and pain: characteristics and treatment patterns from CD PROBE (Cervical Dystonia Patient Registry for Observation of OnabotulinumtoxinA Efficacy)

artículo científico publicado en 2014

Cervical dystonia and substance abuse

scientific article published on 22 March 2018

Cervical dystonia incidence and diagnostic delay in a multiethnic population

artículo científico publicado en 2019

Changes in the relationship between movement velocity and movement distance in primary focal hand dystonia

artículo científico publicado en 2008

Clinical and genetic features of cervical dystonia in a large multicenter cohort

artículo científico publicado en 2016

Clinical and pharmacological properties of incobotulinumtoxinA and its use in neurological disorders

artículo científico

Clinical-Genetic Associations in the Prospective Huntington at Risk Observational Study (PHAROS): Implications for Clinical Trials

artículo científico publicado en 2015

Clinico-immunologic aspects of botulinum toxin type B treatment of cervical dystonia

artículo científico publicado en 2006

Clinimetric testing of the comprehensive cervical dystonia rating scale

artículo científico publicado en 2016

Cognitive and motor function in long-duration PARKIN-associated Parkinson disease

artículo científico publicado en 2014

Cognitive performance of GBA mutation carriers with early-onset PD: the CORE-PD study.

artículo científico publicado en 2012

Comparison of botulinum toxin serotypes A and B for the treatment of cervical dystonia

scientific article published on 01 November 2005

Comparison of methodology, patient characteristics, and treatment results from ANCHOR-CD (abobotulinumtoxinA neurotoxin: Clinical and health economics outcomes registry in cervical Dystonia) and other registry studies of botulinum toxin type A in cer

Control of movement distance in Parkinson's disease

artículo científico publicado en 2001

Correction to: Patient perspectives on the therapeutic profile of botulinum neurotoxin type A in cervical dystonia

artículo científico publicado en 2020

Designing clinical trials for dystonia

scientific article published on January 2014

Development and Validation of the Automated Imaging Differentiation in Parkinsonism (AID-P): A Multi-Site Machine Learning Study

scientific article published on 27 August 2019

Development of the Comprehensive Cervical Dystonia Rating Scale: Methodology

artículo científico publicado en 2015

Differences in brain activation between tremor- and nontremor-dominant Parkinson disease

artículo científico publicado en 2013

Differentiating Tardive Dyskinesia: A Video-Based Review of Antipsychotic-Induced Movement Disorders in Clinical Practice

artículo científico publicado en 2020

Diffusion tensor imaging of Parkinson's disease, atypical parkinsonism, and essential tremor

scientific article published on 14 May 2013

Diffusion, spread, and migration of botulinum toxin

artículo científico publicado en 2013

Dystonia & tremor: A cross-sectional study of the dystonia coalition cohort

artículo científico publicado en 2020

Dystonia rating scales: critique and recommendations

artículo científico publicado en 2013

Effect of High-Intensity Treadmill Exercise on Motor Symptoms in Patients With De Novo Parkinson Disease: A Phase 2 Randomized Clinical Trial

artículo científico publicado en 2017

Effect of medication on EMG patterns in individuals with Parkinson's disease

artículo científico publicado en 2002

Effects of 2 Years of Exercise on Gait Impairment in People With Parkinson Disease: The PRET-PD Randomized Trial

artículo científico publicado en 2017

Effects of Endurance Exercise Training on The Motor and Non-Motor Features of Parkinson's Disease: A Review

artículo científico publicado en 2015

Effects of Endurance Exercise Training on The Motor and Non-Motor Features of Parkinson's Disease: A Review

artículo científico publicado en 2015

Effects of endurance exercise training on the motor and non-motor features of Parkinson's disease: a review.

artículo científico publicado en 2015

Efficacy and Safety of IncobotulinumtoxinA in Subjects Previously Treated with Botulinum Toxin Versus Toxin-Naïve Subjects with Cervical Dystonia

artículo científico publicado en 2013

Efficacy and safety of botulinum type A toxin (Dysport) in cervical dystonia: results of the first US randomized, double-blind, placebo-controlled study

artículo científico publicado en 2005

Efficacy and safety of incobotulinumtoxinA (NT 201, XEOMIN®, botulinum neurotoxin type A, without accessory proteins) in patients with cervical dystonia

artículo científico publicado en 2011

Efficacy and safety of incobotulinumtoxinA (NT 201, Xeomin) in the treatment of blepharospasm-a randomized trial

scientific article published on 22 April 2011

Efficacy and safety of purified botulinum toxin type A (Dysport) for the treatment of benign essential blepharospasm: a randomized, placebo-controlled, phase II trial.

artículo científico publicado en 2008

Estrogen, progesterone, and tic severity in women with Gilles de la Tourette syndrome

artículo científico publicado en 2001

Exercise improves cognition in Parkinson's disease: The PRET-PD randomized, clinical trial

artículo científico publicado en 2015

Factors associated with ambulatory activity in de novo Parkinson disease

artículo científico publicado en 2017

Fatigue in Parkinson's disease: a review

artículo científico publicado en 2007

Fatigue in levodopa-naive subjects with Parkinson disease

artículo científico publicado en 2008

Force control and disease severity in Parkinson's disease

artículo científico publicado en 2005

Force control deficits in individuals with Parkinson's disease, multiple systems atrophy, and progressive supranuclear palsy

artículo científico publicado en 2013

Fosmetpantotenate Randomized Controlled Trial in Pantothenate Kinase-Associated Neurodegeneration

scientific article published on 16 November 2020

Frequency of known mutations in early-onset Parkinson disease: implication for genetic counseling: the consortium on risk for early onset Parkinson disease study

artículo científico publicado en 2010

Genetic and Clinical Predictors of Deep Brain Stimulation in Young-Onset Parkinson's Disease

artículo científico publicado en 2016

Greater impairment of extension movements as compared to flexion movements in Parkinson's disease

scientific article published on 28 January 2004

Head tremor and pain in cervical dystonia

artículo científico publicado en 2021

Head tremor at disease onset: an ataxic phenotype of cervical dystonia

artículo científico publicado en 2019

IncobotulinumtoxinA (Xeomin®) injected for blepharospasm or cervical dystonia according to patient needs is well tolerated

scientific article published on 10 August 2014

Injectable DaxibotulinumtoxinA in Cervical Dystonia: A Phase 2 Dose‐Escalation Multicenter Study.

artículo científico publicado en 2018

It's tricky: Rating alleviating maneuvers in cervical dystonia

artículo científico publicado en 2020

KICK OUT PD: Feasibility and quality of life in the pilot karate intervention to change kinematic outcomes in Parkinson's Disease

artículo científico publicado en 2020

Long-term treatment with botulinum toxin type A in cervical dystonia has low immunogenicity by mouse protection assay

artículo científico publicado en 2008

Longitudinal outcome of Parkinson's disease patients with psychosis

artículo científico publicado en 2003

Longitudinal studies of botulinum toxin in cervical dystonia: Why do patients discontinue therapy?

artículo científico publicado en 2017

Menstrual-related changes in motoric function in women with Parkinson's disease

artículo científico publicado en 2000

Minimal clinically important change in the Toronto Western Spasmodic Torticollis Rating Scale

artículo científico publicado en 2018

Motor phenotype of LRRK2 G2019S carriers in early-onset Parkinson disease

artículo científico publicado en 2009

Multicenter observational study of abobotulinumtoxinA neurotoxin in cervical dystonia: The ANCHOR-CD registry

artículo científico publicado en 2017

Neurite orientation dispersion and density imaging (NODDI) and free-water imaging in Parkinsonism

artículo científico publicado en 2019

Neuropsychological Profile of Parkin Mutation Carriers with and without Parkinson Disease: The CORE-PD Study

artículo científico publicado en 2010

Olfaction in Parkin heterozygotes and compound heterozygotes: the CORE-PD study.

artículo científico publicado en 2010

Parkinson's disease--Part 1: Pathophysiology, symptoms, burden, diagnosis, and assessment.

scientific article published on March 2008

Parkinson's disease--Part 2: Treatment of motor symptoms.

artículo científico publicado en 2008

Parkinson's disease--Part 3: Neuropsychiatric symptoms

artículo científico publicado en 2008

Patient perspectives on the therapeutic profile of botulinum neurotoxin type A in cervical dystonia

scientific article published on 16 September 2020

Physical therapy and Parkinson's disease: a controlled clinical trial

scientific article published on 01 March 1994

Poster 296 AbobotulinumtoxinA Injection Patterns in Patients with Cervical Dystonia from the ANCHOR-CD Registry Study

artículo científico publicado en 2016

Postural Directionality and Head Tremor in Cervical Dystonia

artículo científico publicado en 2020

Practice guideline update summary: Botulinum neurotoxin for the treatment of blepharospasm, cervical dystonia, adult spasticity, and headache

artículo científico publicado en 2016

Pramipexole in patients with early Parkinson's disease (PROUD): a randomised delayed-start trial

artículo científico publicado en 2013

Pre-operative evaluations for DBS in dystonia

artículo científico publicado en 2011

Predictors of alcohol responsiveness in dystonia

artículo científico publicado en 2018

Predictors of parkin mutations in early-onset Parkinson disease: the consortium on risk for early-onset Parkinson disease study

artículo científico publicado en 2010

Primary results from the cervical dystonia patient registry for observation of onabotulinumtoxina efficacy (CD PROBE).

artículo científico publicado en 2014

Progressive resistance exercise restores some properties of the triphasic EMG pattern and improves bradykinesia: the PRET-PD randomized clinical trial

artículo científico publicado en 2016

Quantitative electromyographic analysis of changes in muscle activity following botulinum toxin therapy for cervical dystonia

scientific article published on 01 June 1993

Randomized, double-blind trial of glial cell line-derived neurotrophic factor (GDNF) in PD.

artículo científico publicado en 2003

Rating scale for psychogenic movement disorders: scale development and clinimetric testing

artículo científico publicado en 2005

Rating scales for dystonia: a multicenter assessment.

artículo científico publicado en 2003

Rationale and design of a prospective study: Cervical Dystonia Patient Registry for Observation of OnaBotulinumtoxinA Efficacy (CD PROBE)

artículo científico publicado en 2011

Rationale for delayed-start study of pramipexole in Parkinson's disease: the PROUD study

artículo científico publicado en 2010

Recent developments in drug-induced movement disorders: a mixed picture

scientific article published on 03 July 2019

Recruitment of patients with de novo Parkinson disease: successful strategies in a randomized exercise clinical trial

scholarly article by Deborah A Hall et al published 14 November 2018 in Trials

Reliability of a new scale for essential tremor

artículo científico publicado en 2012

Reliability, feasibility and satisfaction of telemedicine evaluations for Cervical Dystonia

artículo científico publicado en 2019

Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-resistant cervical dystonia

artículo científico publicado en 1999

Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-responsive cervical dystonia

artículo científico publicado en 1999

Scales to assess sleep impairment in Parkinson's disease: critique and recommendations

scientific article published on December 2010

Secured web-based video repository for multicenter studies

artículo científico publicado en 2015

Self-report of cognitive impairment and mini-mental state examination performance in PRKN, LRRK2, and GBA carriers with early onset Parkinson's disease

artículo científico publicado en 2010

Sensory Tricks Are Associated with Higher Sleep-Related Quality of Life in Cervical Dystonia

scientific article published on 17 June 2019

Sleep disorders in Parkinson's disease

scientific article published on 01 January 2011

The Effects of Valbenazine in Participants with Tardive Dyskinesia: Results of the 1-Year KINECT 3 Extension Study.

artículo científico publicado en 2017

The best medicine? The influence of physical activity and inactivity on Parkinson's disease

artículo científico publicado en 2016

The focal dystonias: current views and challenges for future research

scientific article published on June 2013

The relation between depression and parkin genotype: the CORE-PD study

artículo científico publicado en 2011

The relationship between obsessive-compulsive symptoms and PARKIN genotype: The CORE-PD study

artículo científico publicado en 2014

Treatment of early Parkinson's disease. Part 1.

artículo científico publicado en 2009

Treatment of early Parkinson's disease. Part 2.

artículo científico publicado en 2009

Treatment of focal dystonias with botulinum neurotoxin

artículo científico publicado en 2008

Two-year exercise program improves physical function in Parkinson's disease: the PRET-PD randomized clinical trial ⬇️

artículo científico publicado en 2014

Variability of EMG patterns: a potential neurophysiological marker of Parkinson's disease?

artículo científico publicado en 2008

When brawn benefits brain: physical activity and Parkinson's disease risk

artículo científico publicado en 2015

Lista de obras de Cynthia Comella

123 Long-Term Outcomes with Valbenazine 40 mg/day in Adults With Tardive Dyskinesia

140 Effects of Long-Term Valbenazine on Tardive Dyskinesia in KINECT 4: Post Hoc Response and Shift Analyses

77 Long-term Valbenazine Treatment in Patients with Schizophrenia/Schizoaffective Disorder or Mood Disorder and Tardive Dyskinesia

A Phase 3, 1-Year, Open-Label Trial of Valbenazine in Adults With Tardive Dyskinesia

A randomized, controlled trial of remacemide for motor fluctuations in Parkinson's disease

A randomized, double-blind study of repeated incobotulinumtoxinA (Xeomin(®)) in cervical dystonia

A teaching videotape for the assessment of essential tremor

A two-year randomized controlled trial of progressive resistance exercise for Parkinson's disease.

An international survey of patients with cervical dystonia

Assessment: Botulinum neurotoxin for the treatment of movement disorders (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology

Association of daytime napping and Parkinsonian signs in Alzheimer's disease

Basal ganglia hypoactivity during grip force in drug naïve Parkinson's disease

Benefits and Risks of Pharmacological Treatments for Essential Tremor

Beyond a motor disorder: a prospective evaluation of sleep quality in cervical dystonia

Blood oxygenation level-dependent activation in basal ganglia nuclei relates to specific symptoms in de novo Parkinson's disease

CPNP 2020 Annual Meeting Poster Abstracts

Cervical dystonia and pain: characteristics and treatment patterns from CD PROBE (Cervical Dystonia Patient Registry for Observation of OnabotulinumtoxinA Efficacy)

Cervical dystonia and substance abuse

Cervical dystonia incidence and diagnostic delay in a multiethnic population

Changes in the relationship between movement velocity and movement distance in primary focal hand dystonia

Clinical and genetic features of cervical dystonia in a large multicenter cohort

Clinical and pharmacological properties of incobotulinumtoxinA and its use in neurological disorders

Clinical-Genetic Associations in the Prospective Huntington at Risk Observational Study (PHAROS): Implications for Clinical Trials

Clinico-immunologic aspects of botulinum toxin type B treatment of cervical dystonia

Clinimetric testing of the comprehensive cervical dystonia rating scale

Cognitive and motor function in long-duration PARKIN-associated Parkinson disease

Cognitive performance of GBA mutation carriers with early-onset PD: the CORE-PD study.

Comparison of botulinum toxin serotypes A and B for the treatment of cervical dystonia

Comparison of methodology, patient characteristics, and treatment results from ANCHOR-CD (abobotulinumtoxinA neurotoxin: Clinical and health economics outcomes registry in cervical Dystonia) and other registry studies of botulinum toxin type A in cer

Control of movement distance in Parkinson's disease

Correction to: Patient perspectives on the therapeutic profile of botulinum neurotoxin type A in cervical dystonia

Designing clinical trials for dystonia

Development and Validation of the Automated Imaging Differentiation in Parkinsonism (AID-P): A Multi-Site Machine Learning Study

Development of the Comprehensive Cervical Dystonia Rating Scale: Methodology

Differences in brain activation between tremor- and nontremor-dominant Parkinson disease

Differentiating Tardive Dyskinesia: A Video-Based Review of Antipsychotic-Induced Movement Disorders in Clinical Practice

Diffusion tensor imaging of Parkinson's disease, atypical parkinsonism, and essential tremor

Diffusion, spread, and migration of botulinum toxin

Dystonia & tremor: A cross-sectional study of the dystonia coalition cohort

Dystonia rating scales: critique and recommendations

Effect of High-Intensity Treadmill Exercise on Motor Symptoms in Patients With De Novo Parkinson Disease: A Phase 2 Randomized Clinical Trial

Effect of medication on EMG patterns in individuals with Parkinson's disease

Effects of 2 Years of Exercise on Gait Impairment in People With Parkinson Disease: The PRET-PD Randomized Trial

Effects of Endurance Exercise Training on The Motor and Non-Motor Features of Parkinson's Disease: A Review

Effects of Endurance Exercise Training on The Motor and Non-Motor Features of Parkinson's Disease: A Review

Effects of endurance exercise training on the motor and non-motor features of Parkinson's disease: a review.

Efficacy and Safety of IncobotulinumtoxinA in Subjects Previously Treated with Botulinum Toxin Versus Toxin-Naïve Subjects with Cervical Dystonia

Efficacy and safety of botulinum type A toxin (Dysport) in cervical dystonia: results of the first US randomized, double-blind, placebo-controlled study

Efficacy and safety of incobotulinumtoxinA (NT 201, XEOMIN®, botulinum neurotoxin type A, without accessory proteins) in patients with cervical dystonia

Efficacy and safety of incobotulinumtoxinA (NT 201, Xeomin) in the treatment of blepharospasm-a randomized trial

Efficacy and safety of purified botulinum toxin type A (Dysport) for the treatment of benign essential blepharospasm: a randomized, placebo-controlled, phase II trial.

Estrogen, progesterone, and tic severity in women with Gilles de la Tourette syndrome

Exercise improves cognition in Parkinson's disease: The PRET-PD randomized, clinical trial

Factors associated with ambulatory activity in de novo Parkinson disease

Fatigue in Parkinson's disease: a review

Fatigue in levodopa-naive subjects with Parkinson disease

Force control and disease severity in Parkinson's disease

Force control deficits in individuals with Parkinson's disease, multiple systems atrophy, and progressive supranuclear palsy

Fosmetpantotenate Randomized Controlled Trial in Pantothenate Kinase-Associated Neurodegeneration

Frequency of known mutations in early-onset Parkinson disease: implication for genetic counseling: the consortium on risk for early onset Parkinson disease study

Genetic and Clinical Predictors of Deep Brain Stimulation in Young-Onset Parkinson's Disease

Greater impairment of extension movements as compared to flexion movements in Parkinson's disease

Head tremor and pain in cervical dystonia

Head tremor at disease onset: an ataxic phenotype of cervical dystonia

IncobotulinumtoxinA (Xeomin®) injected for blepharospasm or cervical dystonia according to patient needs is well tolerated

Injectable DaxibotulinumtoxinA in Cervical Dystonia: A Phase 2 Dose‐Escalation Multicenter Study.

It's tricky: Rating alleviating maneuvers in cervical dystonia

KICK OUT PD: Feasibility and quality of life in the pilot karate intervention to change kinematic outcomes in Parkinson's Disease

Long-term treatment with botulinum toxin type A in cervical dystonia has low immunogenicity by mouse protection assay

Longitudinal outcome of Parkinson's disease patients with psychosis

Longitudinal studies of botulinum toxin in cervical dystonia: Why do patients discontinue therapy?

Menstrual-related changes in motoric function in women with Parkinson's disease

Minimal clinically important change in the Toronto Western Spasmodic Torticollis Rating Scale

Motor phenotype of LRRK2 G2019S carriers in early-onset Parkinson disease

Multicenter observational study of abobotulinumtoxinA neurotoxin in cervical dystonia: The ANCHOR-CD registry

Neurite orientation dispersion and density imaging (NODDI) and free-water imaging in Parkinsonism

Neuropsychological Profile of Parkin Mutation Carriers with and without Parkinson Disease: The CORE-PD Study

Olfaction in Parkin heterozygotes and compound heterozygotes: the CORE-PD study.

Parkinson's disease--Part 1: Pathophysiology, symptoms, burden, diagnosis, and assessment.